die('
Site is under construction
Dear site users
Site is under construction.
The site will be ready in less than 24 hours.
We are sorry for the inconvenience.
www.yektaweb.com
');
Reports of Biochemistry and Molecular Biology
rbmb.net
Basic Sciences
http://rbmb.net
1
admin
2322-3480
2322-3480
10.61882/rbmb
en
jalali
1398
2
1
gregorian
2019
5
1
8
1
online
1
fulltext
en
The Serum Levels of CCL2 and CCL16 Expression in Patients with Irritable Bowel Syndrome
ایمنی شناسی
Immunology
مقالات اصلی
Original Article
<div style="text-align: justify;"><strong><em>Background:</em></strong> Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by altered bowel habits and abdominal pain in the absence of a recognizable structural anomaly. The pathogenesis of IBS has been associated with inflammation and the expression of pro-inflammatory chemokines, such as CCL2 and CCL16. Our study aimed to investigate the relationship between the serum levels of CCL2 and CCL16 and IBS. Additionally, we examined how serum levels of these chemokines relate to IBS subtypes.<br>
<br>
<strong><em>Methods:</em></strong> Patients with IBS diagnosed according to the Rome III criteria participated in this study (n= 96). Healthy individuals with no history of allergic, autoimmune, chronic or active gastrointestinal infectious diseases were used as controls (n= 44). The serum levels of CCL2 and CCL16 was measured via enzyme-linked immunosorbent assay (ELISA).<br>
<br>
<strong><em>Results:</em></strong> A significant decrease in the serum levels of CCL16 and CCL2 was observed in the patients with IBS. Additionally, the serum levels of CCL16 in IBS patients with diarrhea (D-IBS) was significantly higher than those with the mixed IBS (M-IBS) subtype.<br>
<br>
<strong><em>Conclusions:</em></strong> The significant increase in the serum levels of CCL-16 in patients with D-IBS compared to patients with M-IBS suggests that CCL-16 may be used as an immunological biomarker to differentiate between these two subtypes.<br>
</div>
CCL-2, CCL-16, C-IBS, D-IBS, MCP-1, M-IBS, IBS.
9
14
http://rbmb.net/browse.php?a_code=A-10-48-4&slc_lang=en&sid=1
Mohammad Mahdi
Hayatbakhsh
m24672@yahoo.com
100319475328460017118
100319475328460017118
No
Gastroenterology and Hepatology Research Center, Institute of Basic and Clinical Physiology sciences, Kerman University of Medical Sciences, Kerman, Iran.
Arezoo
Gowhari Shabgah
gohariarezoo@yahoo.com
100319475328460017119
100319475328460017119
No
Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. & Department of Immunology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Saeed
Pishgouyi
dr_s_p_md@yahoo.com
100319475328460017120
100319475328460017120
No
Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.
Jalil
Tavakiol Afshari
tavakolaj@mums.ac.ir
100319475328460017121
100319475328460017121
No
Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. & Department of Immunology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Hadi
Zeidabadi
hadizeydabadi@gmail.com
100319475328460017122
100319475328460017122
No
Department of Gastroenterology, Afzalipour hospital, Kerman University of Medical Sciences, Kerman, Iran.
Mojgan
Mohammadi
mohammadimzh@mums.ac.ir
100319475328460017123
100319475328460017123
Yes
Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. & Allergy Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.